Use of Antipsychotic Drugs Among Residents With Dementia in European Long-Term Care Facilities: Results From the SHELTER Study

Journal of the American Medical Directors Association

Volumn 15, Issue 12, 2014, Pages 911-917

  Foebel, Andrea D ^a,b   Liperoti, Rosa ^b   Onder, Graziano ^b   Finne Soveri, Harriet ^c   Henrard, Jean Claude ^d,e   Lukas, Albert ^f   Denkinger, Michael D ^f   Gambassi, Giovanni ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b CATHOLIC UNIVERSITY   (Italy)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e Versailles Saint Quentin en Yvelines University   (France)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

Antipsychotic drugs; Dementia; Nursing homes

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; MELPERONE; NEUROLEPTIC AGENT; PRESCRIPTION DRUG; QUETIAPINE; RISPERIDONE;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; COHORT ANALYSIS; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DRUG SAFETY; DRUG USE; EUROPE; EUROPEAN MEDICINES AGENCY; FEMALE; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL DISEASE; GERIATRIC PATIENT; GERONTOPSYCHIATRY; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MOOD DISORDER; NURSING HOME PATIENT; PRESCRIPTION; PREVALENCE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RETROSPECTIVE STUDY; SENILE DEMENTIA; SEX RATIO; VULNERABLE POPULATION; CLINICAL PRACTICE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DEMENTIA; LONG TERM CARE; MULTICENTER STUDY; NURSING HOME; STATISTICS AND NUMERICAL DATA;

ACTIVITIES OF DAILY LIVING; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DEMENTIA; EUROPE; FEMALE; HUMANS; ISRAEL; LONG-TERM CARE; MALE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84912080319     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.07.012     Document Type: Article

References (34)

1. Cohen-Mansfield J., Billig N. Agitated behaviours in the elderly I: a conceptual review. JAm Geriatr Soc 1998, 36:7-12.
2. O'Donnell B.F., Drachman D.A., Barnes H.J., et al. Incontinence and troublesome behaviors predict institutionalization in dementia. JGeriatr Psychiatry Neurol 1992, 5:45-52.
3. Steele C., Rovner B., Chase G.A., et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990, 147:1049-1051.
4. De Vugt M.E., Stevens F., Aalten P., et al. Aprospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int Psychogeriatr 2005, 17:577-589.
5. Ryu S.H., Ha J.H., Park D.H., et al. Persistence of neuropsychiatric symptoms over six months in mild cognitive impairment in community-dwelling Korean elderly. Int Psychogeriatr 2011, 23:214-220.
6. Tan L.L., Wong H.B., Allen H. The impact of neuropsychiatric symptoms of dementia on distress in family and professional caregivers in Singapore. Int Psychogeriatr 2005, 17:253-263.
7. Huang S.S., Lee M.C., Liao Y.C., et al. Caregiver burden associated with behavioral and psychological symptoms of dementia (BPSD) in Taiwanese elderly. Arch Gerontol Geriatr 2012, 55:55-59.
8. Hermann N. Recommendations for the management of behavioural and psychological symptoms of dementia. Can J Neuro Sci 2001, 28:96-107.
9. Food and Drug Administration. Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioural disturbances. Available at: . Accessed August 15,2014. http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/drugsafetyinformationforheathcareprofessionals/publichealthadvisories/ucm053171.htm.
10. Food and Drug Administration. Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioural disturbances, 2011 update. Available at: . Accessed July 26,2012. http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm124830.htm.
11. European Medicines Agency. Priorities for drug safety research: Safety aspects of antipsychotics in demented patients. Available at: . Accessed July 26,2012. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/03/WC500076323.pdf.
12. Mitka M. CMS seeks to reduce antipsychotic use in nursing home residents with dementia. JAMA 2012, 308:119-121.
13. Liperoti R., Mor V., Lapane K.L., et al. The use of atypical antipsychotics in nursing homes. JClin Psychiatry 2003, 64:1106-1112.
14. Briesacher B.A., Limcangco M.R., Simoni-Wastila L., et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005, 165:1280-1285.
15. Bronskill S.E., Anderson G.M., Sykora K., et al. Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose and specialist contact. JAm Geriatr Soc 2004, 52:749-755.
16. Rochon P.A., Stukel T.A., Bronskill S.E., et al. Variation in nursing home antipsychotic prescription rates. Arch Intern Med 2007, 167:676-683.
17. Chen Y., Briesacher B., Field T., et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010, 170:89-95.
18. Wetzels R.B., Zuidema S.U., de Jonghe J.F.M., et al. Prescribing patterns of antipsychotic drugs in nursing home residents with dementia. Int Psychogeriatr 2011, 23:1249-1259.
19. Richter T., Mann E., Meyer G., et al. Prevalence of psychotropic medication use among German and Austrian nursing home residents: A comparison of 3 cohorts. JAm Med Dir Assoc 2012, 13:187.e7-187.e13.
20. Azermai M., Elseviers M., Petrovic M., et al. Assessment of antipsychotic prescribing in Belgian nursing home. Int Psychogeriatr 2011, 23:1240-1248.
21. Alanen H.-M. Antipsychotic use among older persons in long-term institutional and home care (Psykoosilääkkeiden käyttö vanhusten pitkäaikaisessa laitos-ja kotihoidossa) 2007, [dissertation], Tampere University Press, Tampere, Finland.
22. Ballard C., Hanney M.L., Theodoulou M., et al. The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomized placebo-controlled trial. Lancet Neurol 2009, 8:151-157.
23. Onder G., Carpenter I., Finne-Soveri H., et al. Assessment of nursing home residents in Europe: The Services and Health for Elderly in Long TERm care (SHELTER) study. BMC Health Serv Res 2012, 12:5.
24. Hirdes J.P., Ljunggren G., Morris J.N., et al. Reliability of the interRAI suite of assessment instruments: A 12-country study of an integrated health information system. BMC Health Serv Res 2008, 8:277.
25. Gray L.C., Berg K., Fries B.E., et al. Sharing clinical information across care settings: the birth of an integrated assessment system. BMC Health Serv Res 2009, 9:71.
26. Landi F., Sgadari A., Zuccala G., et al. Abrief training program on resident assessment instrument improves motivation of nursing home staff. JNutr Health Aging 1999, 3:24-28.
27. Foebel A.D., Hirdes J.P., Heckman G.A., et al. Diagnostic data for neurological conditions in standardized assessments in home care, nursing home and mental health care settings: Avalidity study. BMC Health Serv Res 2013, 13:457. on behalf of the ideas PNC Investigators.
28. Morris J.N., Fries B.E., Morris S.A. Scaling ADLs within the MDS. JGerontol A Biol Sci Med Sci 1999, 54:M546-M553.
29. Morris J.N., Fries B.E., Mehr D.R., et al. MDS Cognitive Performance Scale. JGerontol 1994, 49:M174-M182.
30. Perlman C.M., Hirdes J.P. The aggressive behavior scale (ABS): A new scale to measure aggression based on the MDS. JAm Geriatr Soc 2008, 56:2298-2303.
31. Burrows A., Morris J.N., Simon S., et al. Development of a Minimum Data Set-Based Depression Rating Scale for use in nursing homes. Age Ageing 2000, 29:165-172.
32. Pekkarinen L., Elovainio M., Sinervo T., et al. Nursing working conditions in relation to restraint practices in long-term care units. Med Care 2006, 44:1114-1120.
33. Feng Z., Hirdes J.P., Smith T.F., et al. Use of physical restraints and antipsychotic medications in nursing homes: A cross-national study. Int J Geriatr Psychiatry 2009, 24:1110-1118.
34. Finne-Soveri H., Hammar T., Noro A. Measuring quality of long-term institutional care in Finland. Eurohealth 2010, 16:8-10.